Article Type
Changed
Tue, 08/28/2018 - 11:01
Display Headline
STOP using synthetic mesh for routine repair of pelvic organ prolapse
START performing native tissue repairs and reserve mesh for selective cases

RELATED ARTICLES

Have you read these recent articles in OBG Management about the surgical use of mesh? Click here to access the list.

CASE: Stage 2 prolapse to the hymenal ring

A 54-year-old Para 3 woman presents with stage 2 prolapse to the hymenal ring. The prolapse predominantly involves the anterior vagina, with her cervix prolapsing to 2 cm within the hymenal ring. The patient is bothered by the bulge and stress urinary leakage. She does not want to use a pessary and prefers to have definitive surgical correction, including hysterectomy.

The first surgeon she consulted recommended a vaginal hysterectomy, anterior colporrhaphy, anterior synthetic mesh vaginal colpopexy, and synthetic midurethral sling. The patient was concerned about mesh placement for prolapse and the sling after seeing ads on the Internet about vaginal mesh. She presents for a second opinion about surgical alternatives.

Stop routinely offering synthetic vaginal mesh for prolapse

Advantages to the use of synthetic vaginal mesh include improved subjective and objective cure rates for prolapse (especially for the anterior compartment) and fewer repeat surgeries for recurrent prolapse. However, disadvantages include:

  • mesh exposure and extrusion through the vaginal epithelium
  • overall higher reoperation for mesh-related complications and de novo stress urinary incontinence.1

Synthetic vaginal mesh should be reserved for special situations. Currently, experts agree that synthetic vaginal mesh is appropriate in cases of recurrent prolapse, advanced-stage prolapse, collagen deficiency, or in cases with relative contraindications to longer endoscopic or abdominal surgery, such as medical comorbidities or adhesions.2,3 Other indications for synthetic vaginal mesh include vaginal hysteropexy procedures.

Mesh is likely not necessary in:

  • primary repairs
  • prolapse < POPQ (pelvic organ prolapse quantification system) stage 2
  • posterior prolapse
  • patients with chronic pelvic pain.

Start offering, learning, and mastering native tissue repairs

For the patient in the opening case, who has symptomatic stage 2 uterovaginal prolapse and stress urinary incontinence, surgery, including a transvaginal hysterectomy, anterior colporrhaphy, uterosacral ligament suspension, and synthetic midurethral sling, is a reasonable alternative and has a high subjective and objective cure rate—81.2% rate for anterior prolapse and 98.3% rate for apical prolapse. Better outcomes are noted with stage 2 compared with stage 3 prolapse (92.4% vs 66.8%, respectively).4

Final note

If you are offering selective transvaginal synthetic mesh for prolapse repairs:

  • Undergo training specific to each device.
  • Track your outcomes—including objective, subjective, quality of life, and reoperation for complications and recurrence.
  • Enroll in the national pelvic floor disorders registry, which is scheduled to debut in Fall 2013.

We want to hear from you! Tell us what you think.

References

1. Schmid C, Maher C, Feiner B, Baessler K, Glazener C. 2012 Cochrane Review: Surgical management of pelvic organ prolapse. Int Urogynecol J. 2012;23(suppl 2).-

2. Davila GW, Baessler K, Cosson M, Cardozo L. Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J. 2012;23(suppl 1):S7-S14.

3. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists American Urogynecologic Society. Committee Opinion No. 513: Vaginal placement of synthetic mesh for pelvic organ prolapse. Obstet Gynecol. 2011;118(6):1459-1464.

4. Margulies RU, Rogers MA, Morgan DM. Outcomes of transvaginal uterosacral ligament suspension: systematic review and metaanalysis. Am J Obstet Gynecol. 2010;202(2):124-134.

Article PDF
Author and Disclosure Information

EXPERT COMMENTARY


Cheryl B. Iglesia, MD

Director, Section of Female Pelvic Medicine and Reconstructive Surgery, MedStar Washington Hospital Center, and Associate Professor, Departments of Obstetrics and Gynecology and Urology, Georgetown University School of Medicine, Washington, DC. Dr. Iglesia serves on the OBG Mangement Board of Editors.

The author reports no financial relationships relevant to this article.

Issue
OBG Management - 25(4)
Publications
Topics
Page Number
24-25
Legacy Keywords
Cheryl B. Iglesia MD;Stop Start;synthetic mesh;pelvic organ prolapse;POP;native tissue repair;transvaginal hysterectomy;colporrhaphy;uterosacral ligament suspension;colpopexy;synthetic midurethral sling;mesh exposure;mesh extrusion;vaginal epithelium;reoperation;mesh-related complications;stress urinary incontinence;recurrent prolapse;collagen deficiency;adhesions;vaginal hysteropexy;chronic pelvic pain;national pelvic floor disorders registry;apical prolapse;anterior prolapse;
Sections
Author and Disclosure Information

EXPERT COMMENTARY


Cheryl B. Iglesia, MD

Director, Section of Female Pelvic Medicine and Reconstructive Surgery, MedStar Washington Hospital Center, and Associate Professor, Departments of Obstetrics and Gynecology and Urology, Georgetown University School of Medicine, Washington, DC. Dr. Iglesia serves on the OBG Mangement Board of Editors.

The author reports no financial relationships relevant to this article.

Author and Disclosure Information

EXPERT COMMENTARY


Cheryl B. Iglesia, MD

Director, Section of Female Pelvic Medicine and Reconstructive Surgery, MedStar Washington Hospital Center, and Associate Professor, Departments of Obstetrics and Gynecology and Urology, Georgetown University School of Medicine, Washington, DC. Dr. Iglesia serves on the OBG Mangement Board of Editors.

The author reports no financial relationships relevant to this article.

Article PDF
Article PDF
START performing native tissue repairs and reserve mesh for selective cases
START performing native tissue repairs and reserve mesh for selective cases

RELATED ARTICLES

Have you read these recent articles in OBG Management about the surgical use of mesh? Click here to access the list.

CASE: Stage 2 prolapse to the hymenal ring

A 54-year-old Para 3 woman presents with stage 2 prolapse to the hymenal ring. The prolapse predominantly involves the anterior vagina, with her cervix prolapsing to 2 cm within the hymenal ring. The patient is bothered by the bulge and stress urinary leakage. She does not want to use a pessary and prefers to have definitive surgical correction, including hysterectomy.

The first surgeon she consulted recommended a vaginal hysterectomy, anterior colporrhaphy, anterior synthetic mesh vaginal colpopexy, and synthetic midurethral sling. The patient was concerned about mesh placement for prolapse and the sling after seeing ads on the Internet about vaginal mesh. She presents for a second opinion about surgical alternatives.

Stop routinely offering synthetic vaginal mesh for prolapse

Advantages to the use of synthetic vaginal mesh include improved subjective and objective cure rates for prolapse (especially for the anterior compartment) and fewer repeat surgeries for recurrent prolapse. However, disadvantages include:

  • mesh exposure and extrusion through the vaginal epithelium
  • overall higher reoperation for mesh-related complications and de novo stress urinary incontinence.1

Synthetic vaginal mesh should be reserved for special situations. Currently, experts agree that synthetic vaginal mesh is appropriate in cases of recurrent prolapse, advanced-stage prolapse, collagen deficiency, or in cases with relative contraindications to longer endoscopic or abdominal surgery, such as medical comorbidities or adhesions.2,3 Other indications for synthetic vaginal mesh include vaginal hysteropexy procedures.

Mesh is likely not necessary in:

  • primary repairs
  • prolapse < POPQ (pelvic organ prolapse quantification system) stage 2
  • posterior prolapse
  • patients with chronic pelvic pain.

Start offering, learning, and mastering native tissue repairs

For the patient in the opening case, who has symptomatic stage 2 uterovaginal prolapse and stress urinary incontinence, surgery, including a transvaginal hysterectomy, anterior colporrhaphy, uterosacral ligament suspension, and synthetic midurethral sling, is a reasonable alternative and has a high subjective and objective cure rate—81.2% rate for anterior prolapse and 98.3% rate for apical prolapse. Better outcomes are noted with stage 2 compared with stage 3 prolapse (92.4% vs 66.8%, respectively).4

Final note

If you are offering selective transvaginal synthetic mesh for prolapse repairs:

  • Undergo training specific to each device.
  • Track your outcomes—including objective, subjective, quality of life, and reoperation for complications and recurrence.
  • Enroll in the national pelvic floor disorders registry, which is scheduled to debut in Fall 2013.

We want to hear from you! Tell us what you think.

RELATED ARTICLES

Have you read these recent articles in OBG Management about the surgical use of mesh? Click here to access the list.

CASE: Stage 2 prolapse to the hymenal ring

A 54-year-old Para 3 woman presents with stage 2 prolapse to the hymenal ring. The prolapse predominantly involves the anterior vagina, with her cervix prolapsing to 2 cm within the hymenal ring. The patient is bothered by the bulge and stress urinary leakage. She does not want to use a pessary and prefers to have definitive surgical correction, including hysterectomy.

The first surgeon she consulted recommended a vaginal hysterectomy, anterior colporrhaphy, anterior synthetic mesh vaginal colpopexy, and synthetic midurethral sling. The patient was concerned about mesh placement for prolapse and the sling after seeing ads on the Internet about vaginal mesh. She presents for a second opinion about surgical alternatives.

Stop routinely offering synthetic vaginal mesh for prolapse

Advantages to the use of synthetic vaginal mesh include improved subjective and objective cure rates for prolapse (especially for the anterior compartment) and fewer repeat surgeries for recurrent prolapse. However, disadvantages include:

  • mesh exposure and extrusion through the vaginal epithelium
  • overall higher reoperation for mesh-related complications and de novo stress urinary incontinence.1

Synthetic vaginal mesh should be reserved for special situations. Currently, experts agree that synthetic vaginal mesh is appropriate in cases of recurrent prolapse, advanced-stage prolapse, collagen deficiency, or in cases with relative contraindications to longer endoscopic or abdominal surgery, such as medical comorbidities or adhesions.2,3 Other indications for synthetic vaginal mesh include vaginal hysteropexy procedures.

Mesh is likely not necessary in:

  • primary repairs
  • prolapse < POPQ (pelvic organ prolapse quantification system) stage 2
  • posterior prolapse
  • patients with chronic pelvic pain.

Start offering, learning, and mastering native tissue repairs

For the patient in the opening case, who has symptomatic stage 2 uterovaginal prolapse and stress urinary incontinence, surgery, including a transvaginal hysterectomy, anterior colporrhaphy, uterosacral ligament suspension, and synthetic midurethral sling, is a reasonable alternative and has a high subjective and objective cure rate—81.2% rate for anterior prolapse and 98.3% rate for apical prolapse. Better outcomes are noted with stage 2 compared with stage 3 prolapse (92.4% vs 66.8%, respectively).4

Final note

If you are offering selective transvaginal synthetic mesh for prolapse repairs:

  • Undergo training specific to each device.
  • Track your outcomes—including objective, subjective, quality of life, and reoperation for complications and recurrence.
  • Enroll in the national pelvic floor disorders registry, which is scheduled to debut in Fall 2013.

We want to hear from you! Tell us what you think.

References

1. Schmid C, Maher C, Feiner B, Baessler K, Glazener C. 2012 Cochrane Review: Surgical management of pelvic organ prolapse. Int Urogynecol J. 2012;23(suppl 2).-

2. Davila GW, Baessler K, Cosson M, Cardozo L. Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J. 2012;23(suppl 1):S7-S14.

3. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists American Urogynecologic Society. Committee Opinion No. 513: Vaginal placement of synthetic mesh for pelvic organ prolapse. Obstet Gynecol. 2011;118(6):1459-1464.

4. Margulies RU, Rogers MA, Morgan DM. Outcomes of transvaginal uterosacral ligament suspension: systematic review and metaanalysis. Am J Obstet Gynecol. 2010;202(2):124-134.

References

1. Schmid C, Maher C, Feiner B, Baessler K, Glazener C. 2012 Cochrane Review: Surgical management of pelvic organ prolapse. Int Urogynecol J. 2012;23(suppl 2).-

2. Davila GW, Baessler K, Cosson M, Cardozo L. Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J. 2012;23(suppl 1):S7-S14.

3. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists American Urogynecologic Society. Committee Opinion No. 513: Vaginal placement of synthetic mesh for pelvic organ prolapse. Obstet Gynecol. 2011;118(6):1459-1464.

4. Margulies RU, Rogers MA, Morgan DM. Outcomes of transvaginal uterosacral ligament suspension: systematic review and metaanalysis. Am J Obstet Gynecol. 2010;202(2):124-134.

Issue
OBG Management - 25(4)
Issue
OBG Management - 25(4)
Page Number
24-25
Page Number
24-25
Publications
Publications
Topics
Article Type
Display Headline
STOP using synthetic mesh for routine repair of pelvic organ prolapse
Display Headline
STOP using synthetic mesh for routine repair of pelvic organ prolapse
Legacy Keywords
Cheryl B. Iglesia MD;Stop Start;synthetic mesh;pelvic organ prolapse;POP;native tissue repair;transvaginal hysterectomy;colporrhaphy;uterosacral ligament suspension;colpopexy;synthetic midurethral sling;mesh exposure;mesh extrusion;vaginal epithelium;reoperation;mesh-related complications;stress urinary incontinence;recurrent prolapse;collagen deficiency;adhesions;vaginal hysteropexy;chronic pelvic pain;national pelvic floor disorders registry;apical prolapse;anterior prolapse;
Legacy Keywords
Cheryl B. Iglesia MD;Stop Start;synthetic mesh;pelvic organ prolapse;POP;native tissue repair;transvaginal hysterectomy;colporrhaphy;uterosacral ligament suspension;colpopexy;synthetic midurethral sling;mesh exposure;mesh extrusion;vaginal epithelium;reoperation;mesh-related complications;stress urinary incontinence;recurrent prolapse;collagen deficiency;adhesions;vaginal hysteropexy;chronic pelvic pain;national pelvic floor disorders registry;apical prolapse;anterior prolapse;
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media